Neuphoria Therapeutics Inc.
NEUP | NASDAQ
$3.05
-$0.01 (-0.33%)
At close: Oct 30, 2026, 4:00 PM ET
$3.05
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -1.43 | -30.87 | -82.80 | -165.08 | -607.46 | -2.36K |
PEG Ratio | 0 | -0.24 | 1.42 | -8.25 | -6.07 | 259.16 |
PS Ratio | 16.36 | 0.74 | n/a | n/a | 35.76K | 16.51K |
PB Ratio | 0 | 0.40 | 70.92 | 330.97 | 240.78 | 428.20 |
P/FCF Ratio | 0 | 0.15 | -84.49 | -492.49 | -629.83 | -2.7K |
P/OCF Ratio | 0 | 0.15 | -84.49 | -492.49 | -629.87 | -2.7K |
OCF/S Ratio | -1.05M | 493.49 | n/a | n/a | -5.68K | -610.66 |
Debt / Equity Ratio | 0 | 0.01 | 0.02 | 0.04 | 0.01 | 0.02 |
Quick Ratio | 27.85 | 3.56 | 3.45 | 2.15 | 12.46 | 13.10 |
Current Ratio | 27.85 | 3.56 | 3.45 | 2.15 | 12.46 | 13.10 |
Asset Turnover | 0 | 0.36 | n/a | n/a | 0.01 | 0.02 |
Interest Coverage | n/a | n/a | n/a | n/a | -1.15K | -8.32 |
Return on Equity | -0.05% | -1.28% | -88.58% | -219.65% | -40.31% | -18.27% |
Return on Assets | -0.05% | -0.85% | -56.03% | -165.94% | -35.13% | -16.03% |
Return on Invested Capital | -0.03% | -1.34% | -111.10% | -211.52% | -49.50% | -22.41% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 43.54% | 95.76% | n/a | n/a | -2.6K% | -136.74% |
Net Profit Margin | -1.15K% | -2.36% | n/a | n/a | -5.99K% | -704.49% |
Pretax Profit Margin | -1.16K% | -5.35% | n/a | n/a | -8.33K% | -719.67% |
Operating Profit Margin | -835.53% | -7.21% | n/a | n/a | -8.1K% | -965.74% |
FCF Margin | -1.05M% | 493.49% | n/a | n/a | -5.68K% | -610.78% |
EBITDA Margin | -779.07% | -0.78% | n/a | n/a | -7.9K% | -486.77% |
Add to Watchlist
Select watchlists to add or remove NEUP